MergerLinks Header Logo

Request Deal Involvement

Takeda Pharmaceuticals acquired Shire for $62bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Slaughter & May

legal advisors

Slaughter & May

Davis Polk & Wardwell

legal advisors

Davis Polk & Wardwell

Nagashima Ohno & Tsunematsu

legal advisors

Nagashima Ohno & Tsunematsu

Mourant Ozannes

legal advisors

Mourant Ozannes

Morgan Stanley

brokers

Morgan Stanley

Citigroup

brokers

Citigroup

Ashurst

legal advisors

Ashurst

Goldman Sachs

financial advisors

Goldman Sachs

Citigroup

financial advisors

Citigroup

Morgan Stanley

financial advisors

Morgan Stanley

Ashton Consulting

pr advisors

Ashton Consulting

FTI Consulting

pr advisors

FTI Consulting

Linklaters

legal advisors

Linklaters

Nishimura & Asahi

legal advisors

Nishimura & Asahi

Ogier

legal advisors

Ogier

Latham & Watkins

legal advisors

Latham & Watkins

Nomura

financial advisors

Nomura

JP Morgan

financial advisors

JP Morgan

Evercore

financial advisors

Evercore

Sullivan & Cromwell

legal advisors

Sullivan & Cromwell

JP Morgan

debt providers

JP Morgan

Sumitomo Mitsui Banking Corp

debt providers

Sumitomo Mitsui Banking Corp

Finsbury Glover Hering

pr advisors

Finsbury Glover Hering

A&L Goodbody

legal advisors

A&L Goodbody

Lee & Ko

legal advisors

Lee & Ko

Sard Verbinnen & Co

pr advisors

Sard Verbinnen & Co

MUFG Bank

debt providers

MUFG Bank

or

Principals

SHIRE PLC

target

SHIRE PLC

TAKEDA PHARMACEUTICAL COMPANY LIMITED

bidder

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Takeda Pharmaceuticals acquired Shire for $62bn.